Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / ATOS - Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer | Benzinga


ATOS - Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer | Benzinga

  • SEATTLE, July 02, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), today announced the appointment of Heather Rees as the Company's new Chief Financial Officer (CFO). Ms. Rees most recently served as Atossa's Senior Vice President of Finance and Principal Accounting Officer. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer.

    Ms. Rees brings almost 30-years of accounting, business and financial experience to the CFO role. She has spent the last seven years of her career at Atossa having joined the Company as Controller in 2017. Prior to joining Atossa, Ms. Rees led a consulting practice that delivered financial and accounting services to companies including Getty Images Inc., Flow International Corp, and Avalara, Inc. Earlier in her career she served as Controller of the Americas for Irdeto Inc. She began her career at Deloitte & Touche where she rose to the level of Sr. Manager in the firm's Audit practice. Ms. Rees was licensed as a Certified Public Accountant by the state of Washington in 1996.

    "Heather's partnership and contributions have been invaluable and key to the success of our Company to date, which is why she was the obvious choice to become our new Chief Financial Officer," said Steven Quay, M.D., Ph.D., Atossa's President and Chief Executive Officer. "This appointment is testament to her exemplary performance over the past seven years and the deep industry and functional knowledge she brings to the role. With Heather as our CFO, multiple data milestones coming later this year and a strong balance sheet that provides approximately three years of working capital, we are well positioned to deliver on our mission and to create long-term value for our shareholders."

    "I am excited and proud to be named Atossa's new Chief Financial Officer," said Ms. Rees. "The Company ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: Atossa Therapeutics Inc.
    Stock Symbol: ATOS
    Market: NASDAQ
    Website: atossatherapeutics.com

    Menu

    ATOS ATOS Quote ATOS Short ATOS News ATOS Articles ATOS Message Board
    Get ATOS Alerts

    News, Short Squeeze, Breakout and More Instantly...